Hosted on MSN1y
Bristol Myers (BMY) Gets EC Nod for Abecma's Label ExpansionBristol Myers BMY announced that the European Commission (EC) has approved a label ... Use of the European Medicines Agency had earlier given a positive opinion, recommending Abecma’s approval ...
of the European Medicines Agency (EMA) has adopted a positive opinion recommending authorization of a label extension for IXCHIQ ®, Valneva’s single-dose vaccine for the prevention of disease caused ...
The deal caps a turbulent three years for 2seventy bio. The company served as the oncology business of Bluebird Bio until Bluebird spun out 2seventy in 2021.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results